1H-Indeno(2,1-c)pyridine,2,3-dihydro-2-methyl-9-phenyl-,hydrobromide supplier

Name
2,3-dihydro-2-methyl-9-phenyl-1H-indeno[2,1-c]pyridine hydrobromide
EINECS 276-060-9
CAS No. 71839-14-0
Density
Solubility
Melting Point
Formula C₁₉H₁₇N.BrH
Boiling Point 434.2 °C at 760 mmHg
Molecular Weight 340.263
Flash Point 191.6 °C
Transport Information
Appearance
Safety
Risk Codes
Molecular Structure
Hazard Symbols
Synonyms 1H-Indeno[2,1-c]pyridine,2,3-dihydro-2-methyl-9-phenyl-,hydrobromide (9CI);2-Methyl-9-phenyl-2,3-dihydro-1H-indeno[2,1-c]pyridine hydrobromide (1:1);2,3-Dihydro-2-methyl-9-phenyl-1H-indeno(2,1-c)pyridine hydrobromide;2-Methyl-9-phenyl-2,3-dihydro-1-pyridindene hydrobromide;
PSA 3.24000
LogP 4.72690

1H-Indeno(2,1-c)pyridine,2,3-dihydro-2-methyl-9-phenyl-,hydrobromide Specification

The CAS registry number of 1H-Indeno(2,1-c)pyridine,2,3-dihydro-2-methyl-9-phenyl-,hydrobromide is 71839-14-0. The IUPAC name is 2-methyl-9-phenyl-1,3-dihydroindeno[2,1-c]pyridine hydrobromide. Its EINECS registry number is 276-060-9. In addition, the molecular formula is C₁₉H₁₈BrN and the molecular weight is 340.26. It should be stored in a cool and dry place.

Physical properties about 1H-Indeno(2,1-c)pyridine,2,3-dihydro-2-methyl-9-phenyl-,hydrobromide are: (1)ACD/LogP: 4.06; (2)# of Rule of 5 Violations: 0; (3)#H bond acceptors: 1; (4)#H bond donors: 0; (5)#Freely Rotating Bonds: 1; (6)Polar Surface Area: 3.24 Å²; (7)Flash Point: 191.6 °C; (8)Enthalpy of Vaporization: 69.03 kJ/mol; (9)Boiling Point: 434.2 °C at 760 mmHg; (10)Vapour Pressure: 9.62E-08 mmHg at 25°C.

You can still convert the following datas into molecular structure:
(1)SMILES: Br.C\2=C1/c4c(\C(=C1CN(C/2)C)c3ccccc3)cccc4
(2)InChI: InChI=1/C19H17N.BrH/c1-20-12-11-16-15-9-5-6-10-17(15)19(18(16)13-20)14-7-3-2-4-8-14;/h2-11H,12-13H2,1H3;1H
(3)InChIKey: RFIIQJSREXZMBF-UHFFFAOYAD

The toxicity data is as follows:

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
mouse	LD50	intraperitoneal	150mg/kg (150mg/kg)	PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Journal of Pharmacology and Experimental Therapeutics. Vol. 92, Pg. 249, 1948.
mouse	LD50	intravenous	40mg/kg (40mg/kg)	PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Journal of Pharmacology and Experimental Therapeutics. Vol. 92, Pg. 249, 1948.
mouse	LD50	oral	275mg/kg (275mg/kg)	PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Journal of Pharmacology and Experimental Therapeutics. Vol. 92, Pg. 249, 1948.
mouse	LD50	subcutaneous	260mg/kg (260mg/kg)	PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Journal of Pharmacology and Experimental Therapeutics. Vol. 92, Pg. 249, 1948.

Product Name

2,3-dihydro-2-methyl-9-phenyl-1H-indeno[2,1-c]pyridine hydrobromide

1H-Indeno(2,1-c)pyridine,2,3-dihydro-2-methyl-9-phenyl-,hydrobromide Specification

Related Products

Hot Products